Buys
Open market- Shares
- Avg price
- Total value
Mark Sabag - Executive Vice President, International Markets Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD
Insider Transactions and Holdings
- Entity Type
- Individual
- Role
- Executive Vice President, International Markets Commercial
- Issuer Symbol
- TEVA on NYSE, TEVJF on OTC
- All Insider Reports
- All Insider Reports
Mark Sabag - trading volume in the past year for TEVA PHARMACEUTICAL INDUSTRIES LTD
Sells
Open market- Shares
- -423,174
- Avg price
- $31.07
- Total value
- -$13,147,688
Net
Past year- Shares
- -423,174
- Share %
- -100%
- Total value
- -$13,147,688
Holdings reported by Mark Sabag for TEVA PHARMACEUTICAL INDUSTRIES LTD
Form 4 holding
Executive Vice President, International Markets Commercial
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Ordinary Shares
- Shares / value
- 80,760
- Estimated value
- $2,825,937
- Report date
- 01 May 2026
- Price
- $34.99
- Ownership
- Direct
Form 4 holding
Executive Vice President, International Markets Commercial
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Restricted Share Units
- Shares / value
- 47,170
- Estimated value
- Report date
- 05 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Form 4 holding
Executive Vice President, International Markets Commercial
TEVA PHARMACEUTICAL INDUSTRIES LTD
- Security class
- Stock Options (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 09 Dec 2025
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transactions reported by Mark Sabag for TEVA PHARMACEUTICAL INDUSTRIES LTD
| Sym | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.